219 related articles for article (PubMed ID: 24392316)
1. Preclinical stem cell therapy in Chagas Disease: Perspectives for future research.
de Carvalho KA; Abdelwahid E; Ferreira RJ; Irioda AC; Guarita-Souza LC
World J Transplant; 2013 Dec; 3(4):119-26. PubMed ID: 24392316
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of chronic Chagas heart disease.
Marin-Neto JA; Cunha-Neto E; Maciel BC; Simões MV
Circulation; 2007 Mar; 115(9):1109-23. PubMed ID: 17339569
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological interventions for treating heart failure in patients with chagas cardiomyopathy.
Hidalgo R; Martí-Carvajal AJ; Kwong JS; Simancas-Racines D; Nicola S
Cochrane Database Syst Rev; 2012 Nov; 11():CD009077. PubMed ID: 23152267
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of regenerative cell therapy for pulmonary arterial hypertension in animal models: a preclinical systematic review protocol.
Suen CM; Zhai A; Lalu MM; Welsh C; Levac BM; Fergusson D; McIntyre L; Stewart DJ
Syst Rev; 2016 May; 5():89. PubMed ID: 27225668
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous autologous transplantation of cocultured mesenchymal stem cells and skeletal myoblasts improves ventricular function in a murine model of Chagas disease.
Guarita-Souza LC; Carvalho KA; Woitowicz V; Rebelatto C; Senegaglia A; Hansen P; Miyague N; Francisco JC; Olandoski M; Faria-Neto JR; Brofman P
Circulation; 2006 Jul; 114(1 Suppl):I120-4. PubMed ID: 16820560
[TBL] [Abstract][Full Text] [Related]
6. Current status and perspectives of cell therapy in Chagas disease.
Soares MB; Santos RR
Mem Inst Oswaldo Cruz; 2009 Jul; 104 Suppl 1():325-32. PubMed ID: 19753492
[TBL] [Abstract][Full Text] [Related]
7. Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI).
Nunes MCP; Badano LP; Marin-Neto JA; Edvardsen T; Fernández-Golfín C; Bucciarelli-Ducci C; Popescu BA; Underwood R; Habib G; Zamorano JL; Saraiva RM; Sabino EC; Botoni FA; Barbosa MM; Barros MVL; Falqueto E; Simões MV; Schmidt A; Rochitte CE; Rocha MOC; Ribeiro ALP; Lancellotti P
Eur Heart J Cardiovasc Imaging; 2018 Apr; 19(4):459-460n. PubMed ID: 29029074
[TBL] [Abstract][Full Text] [Related]
8. The impact of Chagas disease control in Latin America: a review.
Dias JC; Silveira AC; Schofield CJ
Mem Inst Oswaldo Cruz; 2002 Jul; 97(5):603-12. PubMed ID: 12219120
[TBL] [Abstract][Full Text] [Related]
9. Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) trial.
Rassi A; Marin JA; Rassi A
Mem Inst Oswaldo Cruz; 2017 Mar; 112(3):224-235. PubMed ID: 28225900
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and management of Chagas disease and cardiomyopathy.
Ribeiro AL; Nunes MP; Teixeira MM; Rocha MO
Nat Rev Cardiol; 2012 Oct; 9(10):576-89. PubMed ID: 22847166
[TBL] [Abstract][Full Text] [Related]
11. Demonstrating efficacy in preclinical studies of cellular therapies for spinal cord injury - how much is enough?
Kwon BK; Soril LJ; Bacon M; Beattie MS; Blesch A; Bresnahan JC; Bunge MB; Dunlop SA; Fehlings MG; Ferguson AR; Hill CE; Karimi-Abdolrezaee S; Lu P; McDonald JW; Müller HW; Oudega M; Rosenzweig ES; Reier PJ; Silver J; Sykova E; Xu XM; Guest JD; Tetzlaff W
Exp Neurol; 2013 Oct; 248():30-44. PubMed ID: 23727091
[TBL] [Abstract][Full Text] [Related]
12. Translational challenges of animal models in Chagas disease drug development: a review.
Chatelain E; Konar N
Drug Des Devel Ther; 2015; 9():4807-23. PubMed ID: 26316715
[TBL] [Abstract][Full Text] [Related]
13. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
14. Robust Cardiac Regeneration: Fulfilling the Promise of Cardiac Cell Therapy.
Selvakumar D; Clayton ZE; Chong JJH
Clin Ther; 2020 Oct; 42(10):1857-1879. PubMed ID: 32943195
[TBL] [Abstract][Full Text] [Related]
15. Multipotent (adult) and pluripotent stem cells for heart regeneration: what are the pros and cons?
Liao SY; Tse HF
Stem Cell Res Ther; 2013 Dec; 4(6):151. PubMed ID: 24476362
[TBL] [Abstract][Full Text] [Related]
16. Stem cells and cardiac repair: a critical analysis.
Dinsmore JH; Dib N
J Cardiovasc Transl Res; 2008 Mar; 1(1):41-54. PubMed ID: 20559957
[TBL] [Abstract][Full Text] [Related]
17. Stem Cell-Based Therapies in Chagasic Cardiomyopathy.
de Carvalho AC; Carvalho AB
Biomed Res Int; 2015; 2015():436314. PubMed ID: 26161401
[TBL] [Abstract][Full Text] [Related]
18. Developments in the management of Chagas cardiomyopathy.
Tanowitz HB; Machado FS; Spray DC; Friedman JM; Weiss OS; Lora JN; Nagajyothi J; Moraes DN; Garg NJ; Nunes MC; Ribeiro AL
Expert Rev Cardiovasc Ther; 2015 Dec; 13(12):1393-409. PubMed ID: 26496376
[TBL] [Abstract][Full Text] [Related]
19. Chagas cardiomyopathy--where do we stand after a hundred years?
Biolo A; Ribeiro AL; Clausell N
Prog Cardiovasc Dis; 2010; 52(4):300-16. PubMed ID: 20109600
[TBL] [Abstract][Full Text] [Related]
20. Cellular therapy in Chagas' disease: potential applications in patients with chronic cardiomyopathy.
Soares MB; Garcia S; Campos de Carvalho AC; Ribeiro dos Santos R
Regen Med; 2007 May; 2(3):257-64. PubMed ID: 17511562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
